Atlas Trials

Efficacy and Safety of Triple-targeted Drug Therapy in Treatment-naive Patients With Non-low-risk PAH: A Real-world, Multicenter Study

Clinical trial NCT06753981 · RECRUITING

Trial details

NCT number
NCT06753981
Sponsor
Qianfoshan Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Arterial Pulmonary Hypertension (PAH)
Start date
2024-12-10
Primary completion
2026-11-14
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.